Ted Yamamoto - Profile and Investment Details

Investor Profile

Ted Yamamoto is a Venture Capital, University Program, Private Equity Firm based in Tokyo, Tokyo, Japan with a diverse investment portfolio that includes companies such as Vegetalia, Seven Dreamers Laboratories, EditForce, AI inside, UTEC - The University of Tokyo Edge Capital, TAGCyx Biotechnologies, Inc., ZenmuTech, Repertoire Genesis, Fressets, Nabiq, SWAT Mobility, Autonomous Control Systems Laboratory, Aidemy, OPALai, CiespaceReasonWhy, MONEY DESIGN, GORYO Chemical, Algal Bio, Nelumbo, Epigeneron, Mujin, Inc., Molcure, CREWT Medical Systems, Inc., Nohla Therapeutics, Locix, Metcela, Liquid, Adacotech, Quantum Biosystems, Tier IV, SEAOS, Phyzios, BionicM, Elixirgen Therapeutics, Tellus You Care, Routrek Networks, MiRTeL, Tricog Health, estie, VividQ, ImmunoScape, FLOSFIA, Wassha, Fyusion, SOCIUM, Startbahn, Green Earth Institute, Retrieva, Waseda University, Institution for a Global Society, BUGWORKS Research, Cyfuse Biomedical, C1X, Neural Pocket, Microwave Chemical, bitBiome, Japan Data Science Consortium, NS Materials, Peptidream, Prometech Software, 908 Devices, GlyTech, Agara, GLM, TXP Medical, PharmaBio, obniz, . Over time, Ted Yamamoto has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Ted Yamamoto is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Education, Technology, Finance, Manufacturing, Biotechnology, Research, Sustainable Energy, Personalized Medicine, UK Startups, Technology Transfer, Renewable Energy, B2B, Quantum Computing may find it worthwhile to explore potential connections with Ted Yamamoto, as their portfolio suggests a familiarity and interest in this area.

Understanding Ted Yamamoto’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.